October 19, 2010
Compensation and compliance – a novel combination
Companies are finally starting to use compensation as a reward for compliance – rather than as a reward for improving the bottom line at any cost. BP just announced that it will base fourth quarter bonuses...
Posted In Whistleblower Law Insights
October 19, 2010
More medical schools providing fraud and abuse instruction, OIG reports
A new report from the Dept. of Health & Human Service’s Inspector General says that forty-four percent of medical schools are providing instruction to students on Medicare and Medicaid fraud...
Posted In Whistleblower Law Insights
October 18, 2010
Government pursues more foreign bribery cases
The government’s prosecution of cases under the Foreign Corrupt Practices Act has resulted in record-shattering fines and criminal convictions of executives. And it seems as though its use will be...
October 18, 2010
Dodd-Frank whistleblower provisions not popular with corporate directors
A survey by Corporate Board Member of more than 400 board members reveals that they are not huge fans of the whistleblower provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act. One...
October 14, 2010
FDA threatens pharma executives with individual penalties for off-label marketing
A round of applause for Food and Drug Administration Deputy Chief for Litigation Eric Blumberg. He said yesterday at a conference in Washington that executives of pharma companies that promote off-label...
Posted In Whistleblower Law Insights
October 12, 2010
CHRISTUS Health will pay nearly $1 million to settle whistleblower suit
CHRISTUS Health, a Texas-based hospital chain, has agreed to pay almost $1 million to settle allegations that it committed Medicare fraud by falsely billing for unapproved medical costs and failing to...
Posted In Whistleblower Law Insights
October 11, 2010
Phillips & Cohen picked for 2010 “Plaintiffs’ Hot List;” recognized for whistleblower work
Phillips & Cohen LLP, the nation’s most successful law firm representing whistleblowers, has been selected for the National Law Journal’s “Hot List” of the Top 12 plaintiffs’ law firms in...
Posted In Whistleblower Law Insights
October 10, 2010
Securities fraud whistleblower exposed Ponzi scheme
The story of a stock trader who went undercover to help the FBI expose a Ponzi scheme shows some of the problems that have confronted the government even when it knows that a fraud is occurring. Ty Schlobohm...
October 06, 2010
Drug companies under investigation for bribing officials overseas
Several large drug companies – including Merck & Co., AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline – have said that they are being investigated for bribing government officials...
Posted In Whistleblower Law Insights
October 01, 2010
Novartis Pharmaceuticals agrees to pay $422.5 million for off-label marketing
Novartis Pharmaceuticals Corporation has agreed to pay $422.5 million in two separate settlements resulting from their alleged off-label drug marketing. According to the accusation, Novartis profited by...
Posted In Whistleblower Law Insights